<DOC>
	<DOCNO>NCT00778245</DOCNO>
	<brief_summary>The objective study ass single - dose relative bioavailability Ranbaxy Bristol-Myers Squibb Company ( CEFZIL Â® ) 500 mg cefprozil tablet , fed condition .</brief_summary>
	<brief_title>Bioequivalence Study Cefprozil Tablets , USP 500 mg Undef Fed Conditions</brief_title>
	<detailed_description>A single dose , randomize , two-period , two-treatment , two-sequence crossover study design use evaluate relative bioavailability cefprozil tablet product dose ( 1 x 500 mg ) feed condition . The washout period least 14 day dos . Twenty four plus two alternate ( 24 + 2 ) subject enrol study volunteer healthy adult . Twenty six ( 24 + 2 ) subject begin study , twenty-five ( 23 + 2 ) subject complete clinical portion study entirety .</detailed_description>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Cefprozil</mesh_term>
	<criteria>Subject candidate must fulfill follow inclusion criterion eligible participation study , unless otherwise specify : 1 . Healthy adult male female volunteer , 18 55 year age 2 . Weighing least 52 kg male 45 kg female within 15 % ideal weight ( table 'Desirable Weights Adults ' , Metropolitan Life Insurance Company , 1983 ) 3 . Medically healthy subject clinically normal laboratory profile ECGs 4 . Females child bear potential either sexually inactive ( abstinent ) 14 day prior first dose throughout study use one follow acceptable birth control method : Surgically sterile ( bilateral tubal ligation , hysterectomy , bilateral oophorectomy ) 6 month minimum IUD place least 3 month Barrier method ( condom , diaphragm ) spermicide least 14 day prior first dose throughout study Surgical sterilization partner ( vasectomy 6 month minimum ) Hormonal contraceptive least 3 month prior first dose study Other birth control method may deem acceptable e ) Post menopausal woman amenorrhea least 2 year eligible f ) Voluntarily consent participate study Subject candidate must enrol study meet follow criterion : 1 . History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease 2 . In addition , history presence : alcohol drug abuse within past year hypersensitivity idiosyncratic reaction cefprozil , cephalosporin antibiotic , penicillin c ) Female subject pregnant lactate ) Subjects special diet ( whatever reason ) 28 day prior first dose throughout study e ) Subjects completion study , would donate excess : 500 mL blood 14 day 1500 mL blood 180 day 2500 mL blood 1 year f ) Subjects participate another clinical trial within 28 day prior first dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence cefprozil 500mg tablet feed condition</keyword>
</DOC>